Choline bitartrate market forecast to reach $736.2 million by 2031

The global choline bitartrate market is projected to grow from $410.2 million in 2021 to $736.2 million by 2031, driven by demand for infant formula, fortified foods and preventive health products. North America held the largest share in 2021, while Asia-Pacific is expected to post the fastest growth through 2031.

Why it matters: - The choline bitartrate market is expanding on demand for infant formula, fortified foods and beverages, and preventive health care products. - Allied Market Research projects the market will nearly double over the decade, reaching $736.2 million by 2031. - The growth outlook points to rising use across pharmaceuticals, nutritional supplements, baby food and adjacent consumer health categories.

What happened: - Allied Market Research published a report on the global choline bitartrate market on June 25, 2026. - The report values the market at $410.2 million in 2021 and forecasts $736.2 million by 2031. - The study projects a compound annual growth rate of 6.1% from 2022 to 2031. - The report covers type, application and regional trends across the global market. - A PDF brochure is available here.

The details: - The L segment held nearly half of the global market in 2021. - The L segment is expected to grow at the fastest CAGR of 7.1% through 2031. - Growth in pharmaceuticals and nutraceuticals is driving demand for the L segment. - The pharmaceutical and nutritional supplement segment held nearly one-third of the market in 2021. - The others segment is projected to post the fastest CAGR of 7.1% from 2022 to 2031. - The others category includes feed additives and personal care and cosmetics. - Choline bitartrate supports cell membrane synthesis and helps maintain B vitamin levels tied to collagen and elastin creation in skin. - North America held nearly two-fifths of the global market in 2021. - Asia-Pacific is expected to grow at the fastest CAGR of 8.0% by 2031. - Rising demand for baby food and newborn formula is supporting Asia-Pacific growth.

Between the lines: - Strong demand from infant nutrition and fortified foods suggests choline bitartrate is benefiting from broader consumer interest in health-oriented products. - The regional growth split suggests mature demand in North America and faster adoption in Asia-Pacific as birth rates and baby food demand support consumption. - The market’s fastest-growing uses outside core supplements signal room for expansion into feed, cosmetics and other applications.

What's next: - The market’s path to 2031 will likely depend on infant formula demand, preventive health trends and regulation around manufacturing standards. - Natural food preferences could pressure some product adoption, while new product development may support growth. - Key companies in the market include Celtic Chemicals Ltd., Cepham Life Sciences, Glentham Life Sciences Ltd., MP Biomedicals, Balchem Inc., Nutragreenlife Biotechnology Co. Ltd., NutriScience Innovations, LLC, Fengchen Group Co. Ltd., TOKYO CHEMICAL INDUSTRY CO., LTD. and Puyer Group. - More information is available in the full report.

The bottom line: - Choline bitartrate is on track for steady global growth, with infant nutrition, supplements and preventive health use cases doing most of the heavy lifting.